GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab

Conditions: Type 1 Diabetes Interventions: Drug: Placebo; Drug: Semaglutide (Rybelsus ®) Sponsors: Vanderbilt University Medical Center Recruiting

Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials